A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy (Q33410791)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy |
scientific article |
Statements
1 reference
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy (English)
1 reference
Sara A Hurvitz
1 reference
Florence Dalenc
1 reference
Mario Campone
1 reference
Ruth M O'Regan
1 reference
Vivianne C Tjan-Heijnen
1 reference
Antonio Llombart
1 reference
Haresh Jhangiani
1 reference
Hamid R Mirshahidi
1 reference
Elizabeth Tan-Chiu
1 reference
Sara Miao
1 reference
Mona El-Hashimy
1 reference
Jeremie Lincy
1 reference
Tetiana Taran
1 reference
Tarek Sahmoud
1 reference
8 October 2013
1 reference
1 reference
141
1 reference
437-446
1 reference
1 October 2013
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference